Mountain Crest Acquisition Corp. V (MCAG)
| Market Cap | 38.13M +17.8% |
| Revenue (ttm) | n/a |
| Net Income | -248.01K |
| EPS | -0.09 |
| Shares Out | 2.87M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 273 |
| Open | 13.27 |
| Previous Close | 13.27 |
| Day's Range | 11.60 - 15.00 |
| 52-Week Range | 11.00 - 15.00 |
| Beta | 0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About MCAG
Mountain Crest Acquisition Corp. V does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Mountain Crest Acquisition Corp. V was incorporated in 2021 and is headquartered in New York, New York. Mountain Crest Acquisition Corp. V is a subsidiary of Mountain Crest Global Holdings LLC. [Read more]
Financial Performance
Financial StatementsNews
Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (the “Company”) (NASDAQ: MCAG), today announced that it received an expected deficiency notification letter from the sta...
CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed
NEW YORK, USA and SEOUL, Korea, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company (“Mountain Crest V”), with ...
Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K and Quarterly Report on Form 10-Q
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (NASDAQ: MCAG, the “Company”) today announced that it received an expected deficiency notification letter from the Listin...
Mountain Crest Acquisition V enters non-binding term sheet with CUBEBIO
Mountain Crest Acquisition Corp. V and CUBEBIO announced that the parties entered into a non-binding term sheet on April 26, 2024 for a proposed business combination through which CUBEBIO plans…
Mountain Crest Acquisition V announces listing transfer to Nasdaq Capital Market
Mountain Crest Acquisition Corp. V received approval from the Nasdaq Stock Market to transfer the listing of its securities from the Nasdaq Global Market to the Nasdaq Capital Market. The…
Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market
NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market (“Nasdaq”) to t...
AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V
SINGAPORE and NEW YORK, Oct. 20, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a clinical-stage biotechnology company, advancing a clinical stage pipeline designed to deploy multi-facete...